UK markets close in 2 hours 34 minutes

Swedish Orphan Biovitrum AB (publ) (SOBI.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
220.10+0.10 (+0.05%)
As of 02:56PM CEST. Market open.
Currency in SEK

Valuation measures4

Market cap (intra-day) 63.43B
Enterprise value 72.14B
Trailing P/E 25.19
Forward P/E 24.81
PEG ratio (5-yr expected) 3.47
Price/sales (ttm)3.79
Price/book (mrq)2.67
Enterprise value/revenue 4.30
Enterprise value/EBITDA 12.74

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 341.25%
S&P500 52-week change 3-9.13%
52-week high 3245.40
52-week low 3153.05
50-day moving average 3214.04
200-day moving average 3209.88

Share statistics

Avg vol (3-month) 3808.62k
Avg vol (10-day) 3660.64k
Shares outstanding 5295.16M
Implied shares outstanding 6N/A
Float 8186.97M
% held by insiders 13.01%
% held by institutions 171.53%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin 15.04%
Operating margin (ttm)25.00%

Management effectiveness

Return on assets (ttm)5.41%
Return on equity (ttm)11.32%

Income statement

Revenue (ttm)16.79B
Revenue per share (ttm)56.90
Quarterly revenue growth (yoy)34.50%
Gross profit (ttm)12.04B
EBITDA 6.08B
Net income avi to common (ttm)2.53B
Diluted EPS (ttm)8.53
Quarterly earnings growth (yoy)-22.00%

Balance sheet

Total cash (mrq)1.06B
Total cash per share (mrq)3.6
Total debt (mrq)9.77B
Total debt/equity (mrq)41.14
Current ratio (mrq)1.03
Book value per share (mrq)80.49

Cash flow statement

Operating cash flow (ttm)5.42B
Levered free cash flow (ttm)4.96B